Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BIT/HLX stock hub

BIT/HLX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/HLXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.2M

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/HLX

In the news

Latest news · BIT/HLX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13P50 15.3P75 18.4

Trailing P/En/a

P25 14.4P50 21.2P75 24.6

ROE-20

P25 3.1P50 8.5P75 13.3

ROIC-22.5

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/HLX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

EUR

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	22
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 15.1M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0005451213
Last refreshed	2026-05-10
Market cap	EUR 15.2M
Price	EUR 0.58
Price currency	EUR
Rev Per Employee	87,826.36x
Sector	Healthcare
Sic	2836
Symbol	bit/HLX
Website	https://www.helyx.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.77%
EV Earnings	-3.44x
EV/FCF	-8.55x
EV/Sales	7.8x
FCF yield	-11.59%
P/B ratio	0.75x
P/S ratio	7.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-233.15%
EBITDA Margin	-81.09%
Gross margin	-3.36%
Gross Profit	EUR -64,842
Net Income	EUR -4.4M
Pretax Margin	-226.51%
Profit Margin	-226.51%
Profit Per Employee	EUR -198,931
ROA	-10.97
Roa5y	-11.89
ROCE	-20.3
ROE	-19.97
Roe5y	-21.12
ROIC	-22.51
Roic5y	-35.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.47%
Cagr3y	-33.36%
Revenue Growth	151.61x
Revenue Growth Q	253.43x
Revenue Growth3 Y	66.19x
Revenue Growth5 Y	84.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.08
Assets	EUR 24M
Cash	EUR 1.3M
Current Assets	EUR 4.8M
Current Liabilities	EUR 1.9M
Debt	EUR 1.1M
Debt Equity	EUR 0.06
Debt FCF	EUR -0.64
Equity	EUR 20.2M
Interest Coverage	-127.6
Liabilities	EUR 3.9M
Long Term Assets	EUR 19.2M
Long Term Liabilities	EUR 2M
Net Cash	EUR 139,028
Net Cash By Market Cap	EUR 0.91
Net Cash Growth	-88.12%
Net Debt Equity	EUR -0.01
Tangible Book Value	EUR 3.1M
Tangible Book Value Per Share	EUR 0.12
WACC	7.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.61
Inventory Turnover	1.14
Net Working Capital	EUR 2M
Quick ratio	1.69
Working Capital	EUR 3M
Working Capital Turnover	EUR 0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.46%
200-day SMA	0.83
3Y total return	-70.41%
50-day SMA	0.68
50-day SMA vs 200-day SMA	50under200
All Time High	7.55
All Time High Change	-92.32%
All Time High Date	2021-08-12
All Time Low	0.56
All Time Low Change	3.57%
All Time Low Date	2026-03-13
ATR	0.02
Beta	0.69
Beta1y	-0.06
Beta2y	0.48
Ch YTD	-27.68
High	0.59
High52	1.4
High52 Date	2025-10-01
High52ch	-58.57%
Low	0.58
Low52	0.56
Low52 Date	2026-03-13
Low52ch	3.57%
Ma50ch	-14.1%
Price vs 200-day SMA	-30.04%
RSI	32.27
RSI Monthly	33.15
RSI Weekly	35.14
Sharpe ratio	-0.22x
Sortino ratio	-0.24
Total Return	-6.4%
Tr YTD	-27.68
Tr1m	-10.77%
Tr1w	-5.23%
Tr3m	-23.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -4.5M
Operating margin	-233.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	789,942
Shares Out	26,049,587
Shares Qo Q	12.81%
Shares Yo Y	6.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.8M
Average Volume	21,550x
Bv Per Share	0.77
CAPEX	EUR -14,278
Ch1m	-10.77
Ch1w	-5.23
Ch1y	-22.46
Ch3m	-23.68
Ch3y	-70.41
Ch6m	-39.58
Change	-0.34%
Change From Open	0
Close	0.58
Days Gap	-0.34
Depreciation Amortization	2,938,032
Dollar Volume	13,920
Earnings Date	2026-06-26
EBIT	EUR -4.5M
EBITDA	EUR -1.6M
EPS	EUR -0.17
F Score	5
FCF	EUR -1.8M
FCF EV Yield	-11.69x
FCF Per Share	EUR -0.07
Financing CF	1,652,037
Fiscal Year End	December
Founded	2,015
Goodwill	16,269,564
Investing CF	-144,407
Is Primary Listing	1
Last Earnings Date	2026-01-05
Last Report Date	2025-12-31
Ma150	0.81
Ma150ch	-28.33%
Ma20	0.62
Ma20ch	-6.47%
Net CF	-240,851
Next Earnings Date	2026-06-26
Open	0.58
Position In Range	0
Ppne	2,029,355
Price Date	2026-05-08
Ptbv Ratio	4.87
Relative Volume	0.78x
Revenue	1,932,180x
Tr6m	-39.58%
Volume	24,000
Z Score	1.57

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIT/HLX pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/HLX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/HLX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.4%

Negative means the company is buying back shares.

Technical

BIT/HLX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.3

Neutral momentum band

Price vs 200-day MA

-30.0%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/HLX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/HLX stock rating?

bit/HLX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/HLX analysis?

The full report lives at /stocks/bit/HLX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/HLX?

The latest report frames bit/HLX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/HLX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.